These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32716212)

  • 1. Safety, efficacy, and tolerability of systemic therapies in male breast cancer: are there sex-specific differences?
    Yadav S; Giridhar KV; Taraba J; Leon-Ferre R; Ruddy KJ
    Expert Opin Drug Saf; 2020 Aug; 19(8):923-926. PubMed ID: 32716212
    [No Abstract]   [Full Text] [Related]  

  • 2. A male with primary breast lymphoma.
    Miura Y; Nishizawa M; Kaneko H; Watanabe M; Tsudo M
    Am J Hematol; 2009 Mar; 84(3):191-2. PubMed ID: 18932237
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapy for male breast cancer.
    Hayes T
    Expert Opin Pharmacother; 2002 Jun; 3(6):701-8. PubMed ID: 12036409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer in men.
    Buzdar AU
    Oncology (Williston Park); 2003 Oct; 17(10):1361-4; discussion 1364, 1369-72. PubMed ID: 14606362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complete remission obtained with letrozole in a man with metastatic breast cancer].
    Italiano A; Largillier R; Marcy PY; Foa C; Ferrero JM; Hartmann MT; Namer M
    Rev Med Interne; 2004 Apr; 25(4):323-4. PubMed ID: 15050804
    [No Abstract]   [Full Text] [Related]  

  • 6. Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access Study.
    Yardley DA; Krop IE; LoRusso PM; Mayer M; Barnett B; Yoo B; Perez EA
    Cancer J; 2015; 21(5):357-64. PubMed ID: 26389758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study.
    Guadagni S; Aigner K; Zoras O; Masedu F; Fiorentini G; Ricevuto E; Deraco M; Clementi M
    Updates Surg; 2019 Mar; 71(1):165-177. PubMed ID: 30542956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
    Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
    J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serpentine supravenous hyperpigmentation induced by docetaxel.
    Das A; Kumar D; Mohanty S; Mondal AK; Chowdhury SN; Bandyopadhyay D
    Indian J Dermatol Venereol Leprol; 2015; 81(4):434. PubMed ID: 25937137
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of anastrozole in male breast cancer.
    Giordano SH; Valero V; Buzdar AU; Hortobagyi GN
    Am J Clin Oncol; 2002 Jun; 25(3):235-7. PubMed ID: 12040279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective angiographically delivered regional chemotherapy in patients with locally advanced or recurrent breast cancer: a feasibility study.
    McCarter DH; Doughty JC; Cooke TG; McArdle CS; Reid AW
    J Vasc Interv Radiol; 1998; 9(1 Pt 1):91-6. PubMed ID: 9468401
    [No Abstract]   [Full Text] [Related]  

  • 12. Male breast cancer in the era of modern therapies: Serbian single centre experience report.
    Popovic L; Trifunovic J; Pesic J; Matovina-Brko G; Kolarov-Bjelobrk I; Memisevic N; Jovanovic D
    Breast J; 2014; 20(3):329-30. PubMed ID: 24708185
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulvestrant in advanced male breast cancer.
    Agrawal A; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2007 Jan; 101(1):123. PubMed ID: 16807672
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial asynchronous bilateral primary male breast carcinoma.
    Karaoglu A; Altundag MK; Erman M; Engin H; Güllü H
    J Exp Clin Cancer Res; 2002 Mar; 21(1):143-4. PubMed ID: 12071522
    [No Abstract]   [Full Text] [Related]  

  • 15. Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
    Diéras V; Miles D; Verma S; Pegram M; Welslau M; Baselga J; Krop IE; Blackwell K; Hoersch S; Xu J; Green M; Gianni L
    Lancet Oncol; 2017 Jun; 18(6):732-742. PubMed ID: 28526536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer or cutaneous lymphoma?
    Spedini P; Morandi S
    Haematologica; 2000 Oct; 85(10):1096. PubMed ID: 11025604
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulvestrant in advanced male breast cancer.
    de la Haba Rodríguez JR; Porras Quintela I; Pulido Cortijo G; Berciano Guerrero M; Aranda E
    Ann Oncol; 2009 Nov; 20(11):1896-7. PubMed ID: 19752001
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of brain metastases from male breast cancer responding to tamoxifen.
    van Rijswijk RE; van Oostenbrugge RJ; Twijnstra A
    Eur J Cancer; 1997 Nov; 33(13):2282-3. PubMed ID: 9470820
    [No Abstract]   [Full Text] [Related]  

  • 19. Trastuzumab and breast cancer.
    Rudlowski C; Rath W; Becker AJ; Wiestler OD; Buttner R
    N Engl J Med; 2001 Sep; 345(13):997-8. PubMed ID: 11575298
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone Therapy for Breast Cancer in Men.
    Khan MH; Allerton R; Pettit L
    Clin Breast Cancer; 2015 Aug; 15(4):245-50. PubMed ID: 26165199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.